Compounds > fludarabine

fludarabine and ribavirin

fludarabine has been researched along with ribavirin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Clauvel, JP; Eftekhari, P; Lassoued, K; Oksenhendler, E; Scieux, C1
Field, K; Seymour, JF; Slavin, MA1

Other Studies

4 other study(ies) available for fludarabine and ribavirin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Severe respiratory syncytial virus pulmonary infection in a patient treated with fludarabine for chronic lymphocytic leukemia.
    Annals of hematology, 1998, Volume: 76, Issue:5

    Topics: Administration, Inhalation; Adult; Antineoplastic Agents; Antiviral Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Vidarabine

1998
Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
    European journal of haematology, 2002, Volume: 69, Issue:1

    Topics: Antineoplastic Agents; Antiviral Agents; Cyclophosphamide; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Respiratory Syncytial Virus Infections; Ribavirin; Vidarabine

2002